Cloning and assembly of immunoglobulin variable regions from hybridomas is now a widely used technology to raise single-chain Fv (scFv) with predefined specificities. Many hybridomas are prepared with fusion partners derived from the mouse myeloma MOPC-21. MOPC-21 produces a normal kappa ( κ ) light chain and an aberrant one with a nonfunctional VJ recombination (MOPC ab Vκ , Accession
No. M35669) (1) .The P3-X63-Ag8.653 and Sp2/O fusion cell lines have been selected from MOPC-21 for their nonexpression of the normal κchain (9). However, MOPC-21 ab VκmRNA is still present in these cells. Sets of oligonucleotides designed to amplify variable regions cannot discriminate between the functional gene derived from the fused B cell and the MOPC-21 transcript. Many groups reported its preferential amplification by reverse transcription polymerase chain reaction (RT-PCR) when attempting to clone the light chain of hybridomas derived from B cells fused to one of these fusion partners (6, 10, 11, 13, 16) .
We recently tried to clone the variable regions of the rat antibody 505.1, directed against the Escherichia coli Glucosamine 6-P Synthase (4). The 505.1 hybridoma was obtained by fusion of rat splenocytes with Sp2/O cells. The 505.1 variable regions of heavy chains (V H ) and light chains (V L ) were first PCR-amplified as previously described (12) . Fragments were subsequently assembled to generate the V H -(GGGGS) 3 -V L insert, which was then cloned into the pSW1 vector (18) . All of the clones sequenced were found to contain the aberrant Vκ derived from MOPC-21.
Several methods have been proposed to avoid the cloning of the MOPC ab Vκ ; however, they are laborintensive or only moderately efficient (6, 10, 11, 13, 16) . Here, we present an efficient and simple method to specifically inhibit the amplification of this aberrant gene with a peptide nucleic acid (PNA) matching its CDR3. PNAs are analogs of oligodeoxynucleotides (2, 7, 14) that form highly stable complexes with complementary DNA but cannot function as primers for DNA polymerases (15 (8) and an elevated melting temperature (T m ) (66°C) determined as recommended by the manufacturer. Six nucleotides separate the carboxy-terminus of the PNA from the 3 ′ end of the antisense Vκ primer, a number that could be critical for PCR clamping (15) but that was nonetheless mandatory based on the two defined criteria.
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The conditions of PNA inhibition were first optimized with a plasmid carrying the aberrant MOPC-21 Vκ (Figure 1) . When TaqDNA Polymerase (AmpliTaq ® ; PE Biosystems, Foster City, CA, USA) was used, only a partial PCR inhibition was observed (PNA concentrations: 2.5-25 µ M) (not shown). Possibly, PNA was removed during elongation, due to the strand displacement activity of the enzyme.
By contrast, the AmpliTaq DNA Polymerase, Stoffel Fragment (PE Biosystems, Foster City) was more efficient than TaqDNA Polymerase, with an almost total inhibition of the MOPC ab Vκamplification in presence of 2.5 µ M of PNA. In the same conditions, amplification of 3 control Vκ was unaffected by PNA (Figure 1) .
We then evaluated whether PNA inhibition could be used to clone the Vκ gene from the 505.1 hybridoma that contains the MOPC ab Vκ . We first cloned the 505.1 light chain using another approach: since the 505.1 monoclonal antibody (MAb) is a rat antibody, the amplification of the light chain was done with the Vκ 2-Back primer (3) and with the primer Rat -C κ For (5 ′ -AGGATCCAGTTGCTAA-CTGTTCCG-3 ′ ), which specifically anneals to the rat C κ domain and not to the mouse gene (not shown). The PCR product was re-amplified with the nested primer pair Vκ 2Back/Vκ 4For (3) with added restriction sites and cloned into pSW1. Sequencing revealed the presence of two variable light chains. One chain (505.1 ab Vκ ) was nonfunctional due to the presence of two stop codons, the other chain (505.1 Vκ ) was functional. Based on the 505.1 Vκse -quence, an oligonucleotide (CDR κ 505: 5 ′ -TGTAGGAGGATTATCATATG-3 ′ ) specific for the CDR3 was designed for further PCR screening.
We then determined the amplification pattern of the Vκdomain with a cDNA prepared from the 505.1 hybridoma in the presence or absence of PNA. Two independent PCRs (reac - (15, 17) . The method presented here shows the usefulness of PNA for scFv cloning from hybridomas. The only changes in usual scFv cloning protocols (12, 18) involve the addition of 10 µ M PNA in the RT-PCR cocktail and the use of Stoffel fragment polymerase with modified cycling conditions. This approach could be extended by designing PNAs matching the CDR3s of other known V regions whose mRNAs are transcribed by fusion partners [e.g., the rat κ -chain Y3 Ag 1.2.3 (5) and the mouse aberrant Vκ 45 T00.IL1 derived from MPC11 (19) ]. It represents a versatile tool to improve the reliable cloning of the variable regions specifically produced by hybridomas.
